Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Laquinimod in Relapsing-Remitting Multiple Sclerosis
Dimethylfumarate induces apoptosis in human mast cells.
Regulation of dimethyl-fumarate toxicity by proteasome inhibitors.
Immuno-modulatory Properties of a Quinolin-2-(1H)-on-3-carboxamide Derivative: Relevance in Multiple Sclerosis.
Mutation Analysis of Gap Junction Protein Beta 1 and Genotype-Phenotype Correlation in X-linked Charcot-Marie-Tooth Disease in Chinese Patients.
Multi-parametric quantitative MRI of normal appearing white matter in multiple sclerosis, and the effect of disease activity on T2.
UCSF Seminar: "The needle in the haystack: Searching for target antigens of the adaptive immune response in MS."
Natalizumab plus interferon beta-1a for relapsing multiple sclerosis.
Association between the three functional miR-146a single-nucleotide polymorphisms, rs2910164, rs57095329, and rs2431697, and autoimmune disease susceptibility: A meta-analysis.
Urinary incontinence in multiple sclerosis: prevalence, severity and impact on patients' quality of life.
[Neurophysiology in Guillain-Barré syndrome].
Fumaric acid esters promote neuronal survival upon ischemic stress through activation of the Nrf2 but not HIF-1 signaling pathway.
Timing of birth and risk of multiple sclerosis: population based study.
Pharmacokinetics and pharmacodynamics of IFN-beta 1a in healthy volunteers.
Assessment of structural and functıonal vısual outcomes ın relapsıng remıttıng multıple sclerosıs wıth vısual evoked potentıals and optıcal coherence tomography.
Multiple sclerosis prevalence in the United States commercially insured population.
Brain Cholesterol Metabolism and Its Defects: Linkage to Neurodegenerative Diseases and Synaptic Dysfunction.
WT1 and interferon-β-vitamin D association in MS: a longitudinal study.
Social Media Representation of Chronic Cerebrospinal Venous Insufficiency Intervention for Multiple Sclerosis.
Akt Regulates Axon Wrapping and Myelin Sheath Thickness in the PNS.
Trimesta (Oral Estriol)
Biogen slips as FDA extends review of MS drug
American Neurological Association Annual 2012 Annual Meeting
TECFIDERA® (Dimethyl Fumarate) Data Reinforce Strong, Sustained Efficacy for Newly-Diagnosed MS Patients
Rebif approval application

Pages